Pure Bioscience Balance Sheet (2010-2026)

Reported Financials

Pure Bioscience Quarterly Balance Sheet

Periods 63 quarters

Latest Apr 2026

Pure Bioscience reported total assets of $1.56M and total liabilities of $7.40M for the quarter ended Apr 2026, up 47.4% year over year. This balance sheet covers 63 quarters of results from Oct 2010 through Apr 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet	Jul2021	Oct2021	Jan2022	Apr2022	Jul2022	Oct2022	Jan2023	Apr2023	Jul2023	Oct2023	Jan2024	Apr2024	Jul2024	Oct2024	Jan2025	Apr2025	Jul2025	Oct2025	Jan2026	Apr2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	2.39M	1.76M	1.13M	0.51M	3.39M	2.45M	1.49M	0.78M	1.10M	1.44M	0.56M	0.44M	0.35M	0.35M	0.20M	0.54M	0.33M	0.43M	0.20M	0.98M
Cash & Current Investments	2.39M	1.76M	1.13M	0.51M	3.39M	2.45M	1.49M	0.78M	1.10M	1.44M	0.56M	0.44M	0.35M	0.35M	0.20M	0.54M	0.33M	0.43M	0.20M	0.98M
Receivables - NetNet Receivables	0.37M	0.24M	0.21M	0.20M	0.20M	0.25M	0.16M	0.19M	0.29M	0.35M	0.17M	0.23M	0.30M	0.37M	0.18M	0.29M	0.47M	0.39M	0.25M	0.24M
Receivables - OtherOther Receivables
Receivables	0.37M	0.24M	0.21M	0.20M	0.20M	0.25M	0.16M	0.19M	0.29M	0.35M	0.17M	0.23M	0.30M	0.37M	0.18M	0.29M	0.47M	0.39M	0.25M	0.24M
Raw Materials	0.02M	0.02M	0.02M	0.02M	0.02M	0.02M	0.03M	0.03M	0.01M	0.02M	0.02M	0.02M	0.00M	0.00M	0.00M	0.02M	0.01M	0.02M	0.02M	0.01M
Finished Goods	0.32M	0.30M	0.28M	0.28M	0.16M	0.22M	0.17M	0.12M	0.08M	0.09M	0.06M	0.06M	0.05M	0.07M	0.07M	0.11M	0.13M	0.22M	0.23M	0.22M
Inventory	0.33M	0.31M	0.30M	0.30M	0.18M	0.24M	0.20M	0.15M	0.09M	0.10M	0.07M	0.07M	0.06M	0.07M	0.08M	0.13M	0.14M	0.24M	0.24M	0.23M
Prepaid Assets	0.03M	0.07M	0.03M	0.03M	0.02M	0.05M	0.02M	0.04M	0.06M	0.10M	0.06M	0.04M	0.03M	0.05M	0.03M	0.01M	0.02M	0.04M	0.01M	0.02M
Current Assets	3.20M	2.45M	1.74M	1.11M	3.86M	3.07M	1.94M	1.23M	1.60M	2.07M	0.94M	0.87M	0.81M	0.91M	0.56M	1.05M	1.05M	1.18M	0.78M	1.55M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)	0.74M	0.77M	0.73M	0.70M	0.62M	0.63M	0.59M	0.59M	0.22M	0.18M	0.15M	0.05M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M
Intangibles	0.37M	0.33M	0.32M	0.31M
Goodwill & Intangibles	0.37M	0.33M	0.32M	0.31M
Other Non-Current Assets	0.08M	0.08M	0.08M	0.08M	0.08M	0.08M	0.08M	0.08M	0.08M	0.08M	0.08M	0.08M	0.08M	0.08M	0.08M	0.08M	0.08M	0.08M	0.08M	0.08M
Non-Current Assets	1.11M	1.10M	1.05M	1.01M	0.62M	0.63M	0.59M	0.59M	0.22M	0.18M	0.15M	0.05M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M
Assets	4.30M	3.56M	2.79M	2.12M	4.48M	3.70M	2.53M	1.82M	1.83M	2.25M	1.09M	0.92M	0.82M	0.92M	0.57M	1.06M	1.06M	1.19M	0.79M	1.56M
Liabilities
Current Liabilities
Accounts Payables	0.59M	0.47M	0.43M	0.42M	0.49M	0.56M	0.35M	0.43M	0.42M	0.65M	0.41M	0.51M	0.60M	0.72M	0.70M	0.80M	0.78M	0.88M	0.77M	0.72M
Notes Payables									1.02M				2.95M	3.51M	3.98M	4.90M		2.10M	2.14M	2.75M
Payables	0.59M	0.47M	0.43M	0.42M	0.49M	0.56M	0.35M	0.43M	1.44M	0.65M	0.41M	0.51M	3.55M	4.23M	4.68M	5.70M	0.78M	2.98M	2.91M	3.47M
Accumulated Expenses	0.14M	0.12M	0.16M	0.13M	0.09M	0.14M	0.12M	0.14M	0.11M	0.15M	0.14M	0.16M	0.13M	0.19M	0.17M	0.17M	0.15M	0.18M	0.15M	0.18M
Other Accumulated Expenses				0.14M				0.09M
Short term Debt	0.24M	0.24M
Current Deferred Revenue
Total Current Liabilities	0.97M	0.83M	0.58M	0.55M	0.58M	0.70M	0.46M	0.57M	0.53M	0.81M	0.55M	0.67M	0.73M	0.91M	0.87M	0.97M	0.94M	3.16M	3.06M	3.65M
Non-Current Liabilities
Non-Current Debt									1.02M	1.83M	1.86M	2.40M	2.95M	3.51M	3.98M	4.90M	5.24M	5.68M	6.15M	6.50M
Convertible Debt													2.95M				5.24M	5.15M	5.52M	5.77M
Other Non-Current Liabilities
Total Non-Current Liabilities									1.02M	1.83M	1.86M	2.40M	2.95M	3.51M	3.98M
Total Liabilities	0.97M	0.83M	0.58M	0.55M	0.58M	0.70M	0.46M	0.57M	1.55M	2.63M	2.41M	3.07M	3.68M	4.42M	4.84M	5.87M	6.17M	6.73M	7.06M	7.40M
Shareholder's Equity
Total Debt	0.24M	0.24M							1.02M	1.83M	1.86M	2.40M	2.95M	3.51M	3.98M	4.90M	5.24M	7.78M	8.28M	9.25M
Common Equity	3.33M	2.73M	2.21M	1.57M	3.91M	3.00M	2.07M	1.26M	0.27M	-0.38M	-1.32M	-2.15M	-2.86M	-3.50M	-4.27M	-4.81M	-5.12M	-5.55M	-6.27M	-5.84M
Liabilities and Shareholders Equity	4.30M	3.56M	2.79M	2.12M	4.48M	3.70M	2.53M	1.82M	1.83M	2.25M	1.09M	0.92M	0.82M	0.92M	0.57M	1.06M	1.06M	1.19M	0.79M	1.56M
Retained Earnings	-125.79M	-127.00M	-127.29M	-128.05M	-129.28M	-130.28M	-131.34M	-132.21M	-133.25M	-133.98M	-134.98M	-135.84M	-136.60M	-137.28M	-138.08M	-138.66M	-138.99M	-139.46M	-140.24M	-140.87M

Pure Bioscience Balance Sheet API

Pull Pure Bioscience's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PURE&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "PURE", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=PURE&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Pure Bioscience PURE Balance Sheet (2010-2026)

Pure Bioscience Quarterly Balance Sheet

Pure Bioscience Balance Sheet API

Create an account

Sign In

Reset Password